| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.6 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.6 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |